TICKERNERD
Menu
USNAUSNAConsumer Defensive · Packaged Foods

USNA Stock Forecast: USANA Health Sciences, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$14
+2.88% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 73 of 100 as at 22 Aug 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$250.4M
Ticker Nerd rank
73 / 100
Median analyst target
$25
Analysts covering
0
Total return, dividends reinvested
1W
+1.4%
1M
−38.7%
YTD
−30.9%
1Y
−55.7%
From 52W high
−57.9%
From 52W low
+5.4%
$13
$32
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

USNA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores USANA Health Sciences, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
73 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
99
Volatility
86
Accruals
85
Quality
72
Issuance
71
Size
65
Growth
42
Revisions
32
Momentum
19

Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (19): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

USNA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on USNA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$15$20$25$30Oct 25Jan 26Apr 26Jul 26USNAHigh $25Median $25Low $25

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 Feb 2025DA DavidsonMaintainsNeutral$38 → $36
27 Feb 2025DA DavidsonMaintainsNeutral—
2 Jan 2025DA DavidsonMaintainsNeutral—
23 Oct 2024DA DavidsonMaintainsNeutral—
25 July 2024DA DavidsonMaintainsNeutral—
7 May 2024DA DavidsonMaintainsNeutral—
22 Feb 2024DA DavidsonMaintainsNeutral—
25 Oct 2023DA DavidsonMaintainsNeutral—
26 Apr 2023DA DavidsonMaintainsNeutral—
13 Feb 2023DA DavidsonMaintainsNeutral—
27 Oct 2022DA DavidsonMaintainsNeutral—
28 July 2022DA DavidsonMaintainsNeutral—
12 July 2022DA DavidsonMaintainsNeutral—
7 July 2022JefferiesDowngradeUnderperform—
27 Apr 2022DA DavidsonMaintainsNeutral—
14 Apr 2022DA DavidsonInitiatesNeutral—
10 Feb 2021Roth CapitalMaintainsBuy—
17 Dec 2020Roth CapitalInitiatesBuy—
22 Aug 2019JefferiesInitiatesHold—
3 July 2019Sidoti & Co.DowngradeNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. USNA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

USNA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−64.2%
Analysts raising
0
Analysts cutting
1
Fundamentals

USANA Health Sciences, Inc. (USNA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
27.3×

Cheaper than 29% of US stocks

Price / sales
0.3×

Cheaper than 90% of US stocks

Price / book
0.5×

Cheaper than 86% of US stocks

EV / EBITDA
1.7×

Cheaper than 57% of US stocks

Growth & margins
Revenue growth (YoY)
−5.3%

Higher than 19% of US stocks

Earnings growth (YoY)
−20.1%

Higher than 20% of US stocks

Gross margin
76.2%

Higher than 88% of US stocks

Operating margin
4.1%

Higher than 53% of US stocks

Net margin
−2.4%

Higher than 27% of US stocks

Returns & dividend
Return on equity
−5.1%

Higher than 39% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

USNA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
USNAUSANA Health Sciences, Inc.$250.4M
73
NATRNature's Sunshine Products, Inc.$250.9M
88
BYNDBeyond Meat, Inc.$254.0M
29
BGSB&G Foods, Inc.$276.7M
59
BRCCBRC, Inc.$217.8M
81
PREPrenetics Global Ltd.$339.9M
48
LWAYLifeway Foods, Inc.$392.8M
41

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own USANA Health Sciences, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest USNA news & analysis

USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix

PRNewsWire · 17 Aug 2026positive

USANA Health Sciences announced the launch of Clear Protein + Creatine Mix, a new 3-in-1 drink combining 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in a 50-calorie serving. The product is designed to simplify active adults' routines by replacing separate protein, creatine, and hydration products.

Why it matters — A USNA watcher would care because the new product launch expands the company's active-nutrition portfolio and could support its product lineup in the competitive sports nutrition market.

Why Usana Health Sciences Stock Plummeted This Week

The Motley Fool · 9 Aug 2026negative

Usana Health Sciences reported second-quarter earnings and sales that came in well below expectations. The company now expects to record a loss for the full year.

Why it matters — A full-year loss forecast and below-expectation quarterly results signal a meaningful deterioration in Usana's near-term financial outlook for shareholders and prospective investors.

USANA Health Sciences Q2 Earnings Call Highlights

MarketBeat · 9 Aug 2026negative

USANA Health Sciences reported that its core nutritional business met expectations in Q2 2026, but near-term challenges at its Hiya and Rise Wellness ventures led the company to lower its full-year outlook.

Why it matters — USNA watchers would care because the lowered full-year outlook signals headwinds from the company's wellness ventures despite a stable core business.

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

Seeking Alpha · 5 Aug 2026negative

USANA Health Sciences shares fell sharply after second-quarter earnings. The direct selling business continued to shrink, and its growth brands Hiya and Rise Wellness underperformed, with revenues plummeting and their 2026 guidance cut substantially.

Why it matters — USNA watchers would care because the company's two growth brands struggled and their outlook was reduced, suggesting limited remaining growth drivers for the business.

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

Seeking Alpha · 5 Aug 2026neutral

Seeking Alpha published the transcript of USANA Health Sciences, Inc.'s Q2 2026 earnings call. The item comprises the company's second-quarter 2026 earnings call presentation.

Why it matters — A USNA watcher would care because the earnings call transcript provides direct details on the company's second-quarter 2026 financial results and management commentary.

FAQ

Frequently asked questions about USNA stock

How does Ticker Nerd's model rank USNA?

As at 22 Aug 2026, USANA Health Sciences, Inc. ranks 73 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).

What is the USNA stock forecast for 2030?

No analyst covering USANA Health Sciences, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for USNA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $25 over the next 12 months.

How has USNA stock performed over the past year?

USANA Health Sciences, Inc. returned -55.7% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does USANA Health Sciences, Inc. do?

Usana Health Sciences, Inc. is a prominent player in the healthcare and wellness sector, primarily focused on the development and distribution of nutritional supplements and personal care products.

What is the latest news on USNA?

The most recent item we track (PRNewsWire, 17 Aug 2026): "USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix". USANA Health Sciences announced the launch of Clear Protein + Creatine Mix, a new 3-in-1 drink combining 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in a 50-calorie serving. The product is designed to simplify active adults' routines by replacing separate protein, creatine, and hydration products.

Company

About USANA Health Sciences, Inc.

Usana Health Sciences, Inc. is a prominent player in the healthcare and wellness sector, primarily focused on the development and distribution of nutritional supplements and personal care products. The company is renowned for its high-quality vitamins, dietary supplements, and skin and personal care items, aiming to enhance well-being and support healthy living. Usana operates on a global scale, selling its products through a direct selling model, which not only markets its portfolio but also empowers entrepreneurs around the world. Established in 1992, Usana Health Sciences has carved a niche in the wellness industry by prioritizing scientific research and development to ensure product efficacy and safety. The company's innovative approach and dedication to quality have made it a trusted name among health-conscious consumers and medical professionals alike. Usana plays a significant role in the broader health and wellness market, contributing to the global trend towards preventive health measures and personalized healthcare solutions.

CEO Mr. Kevin G. Guest · 1,570 employees · United States · https://www.usana.com